Nitric oxide is not licensed for preterm neonates

BMJ 2002; 325 doi: http://dx.doi.org/10.1136/bmj.325.7374.1244/a (Published 23 November 2002)
Cite this as: BMJ 2002;325:1244.2

Get access to this article and all of bmj.com for the next 14 days

Sign up for a 14 day free trial today

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Charles E M Normand, head (charles.normand@lshtm.ac.uk),
  2. David Field, professor,
  3. Diana Elbourne, professor of healthcare evaluation,
  4. Ann Truesdale, INNOVO trial coordinator
  1. Department of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London WC1E 7HT
  2. Neonatal Unit, Leicester Royal Infirmary, Leicester LE1 5WW
  3. London School of Hygiene and Tropical Medicine

    EDITOR—We agree with Pierce et al that attention should be drawn to the potential high cost of nitric oxide after the granting of its licence.1 The use of nitric oxide is not licensed for treating preterm neonates. The currently published evidence does not support the use of inhaled nitric oxide in preterm …

    Get access to this article and all of bmj.com for the next 14 days

    Sign up for a 14 day free trial today

    Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    THIS WEEK'S POLL